Origin Agritech Limited announced the reappointment of Dr. Zheng James Chen as Chief Financial Officer and the appointment of Dr. Jian Zhang as an independent board member, both effective March 20, 2026. Dr. Chen, who previously served as CFO, brings deep institutional knowledge and a track record of managing the company’s finances through periods of growth and restructuring. Dr. Zhang, a globally recognized expert in crop biotechnology, joins the board to strengthen the company’s technical leadership and support its expansion of proprietary seed technologies.
The company’s financial performance in the most recent fiscal year underscored the urgency of these leadership changes. Revenue fell to RMB 91.3 million (US$12.8 million) from RMB 113.4 million (US$16.2 million) in the prior year, while the company recorded a net loss of RMB 53.3 million (US$7.5 million) versus a net income of RMB 20.7 million (US$3.0 million) in fiscal 2024. The decline was driven by capital‑intensive upgrades at the Xinjiang factory, a reduction in external seed‑production services, and lower sales of non‑proprietary varieties.
The CFO’s return is intended to navigate a challenging capital environment that includes tighter credit conditions and cautious investor sentiment in the agricultural‑technology sector. Dr. Chen’s experience in cost control and cash‑flow management is expected to help the company maintain a solid balance sheet—holding more cash than debt—while pursuing strategic investments. The addition of Dr. Zhang is aimed at accelerating the commercialization of the company’s proprietary seed pipeline, which features glyphosate‑tolerant and Bt‑trait varieties and is supported by partnerships with academic institutions such as China Agricultural University.
Origin’s management has emphasized that the new leadership will drive the company’s biotech commercialization strategy. Chairman Gengchen Han stated, “We are building Origin around the most capable leadership team we have fielded.” The CFO’s financial expertise and the board member’s technical credentials are expected to provide the governance and operational support needed to scale the company’s seed portfolio, secure additional funding, and manage the costs associated with research and development and market expansion.
The appointments signal a strategic pivot toward strengthening both financial stewardship and scientific innovation. With a clear focus on advancing its seed pipeline and improving operational efficiency, Origin aims to position itself for long‑term growth despite the current headwinds in revenue and profitability.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.